Lara Sanchez-Barroso
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lara Sanchez-Barroso has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Arturo Cano-Uceda
Faculty of Nursing, Physiotherapy and Podiatry, Complutense University of Madrid, 28040 Madrid, Spain
2 shared publications - Catalina Santiago
ESBIDA Research Group, Department of Rehabilitation, Faculty of Medicine, Health and Sports, Universidad Europea de Madrid, Madrid, Spain
2 shared publications Isabel María Sánchez Lorente
ESBIDA Research Group, Department of Sport Sciences, Faculty of Medicine, Health and Sports, Universidad Europea de Madrid, Madrid, Spain
2 shared publications- José Luis Maté-Muñoz
Department of Physiotherapy, Complutense University of Madrid, Spain
2 shared publications - Luis De Sousa-De Sousa
Department of Radiology, Rehabilitation and Physiotherapy, Faculty of Nursing, Physiotherapy and Podiatry, Complutense University of Madrid, Madrid, Spain
2 shared publications - Mar Larrosa
Department of Nutrition and Food Science, Faculty of Pharmacy, Universidad Complutense de Madrid, Madrid, Spain
2 shared publications
Latest Publications
- Open Access
Effects of a 6-Week Supervised Multimodal Exercise Program on Cancer-Related Fatigue, Quality of Life and Physical Function During Active Treatment: A Randomized Controlled Trial
Background: Reduced quality of life, cancer-related fatigue, and functional impairment are common during and after oncologic treatment. Although therapeutic exercise is effective, evidence on brief, supervised programs of moderate to vigorous intensity remains limited, despite their greater clinical feasibility. This study evaluated the effectiveness of a six-week multimodal Therapeutic Exercise Program (TEP) in patients with cancer. Methods: A randomized controlled clinical trial (NCT05816187) was conducted with 110 patients with cancer (stages I–III), assigned to either an intervention group (supervised TEP, three sessions per week for six weeks) or a control group (usual care). The program included cardiorespiratory and strength training with intensity monitored using the Rating of Perceived Exertion (RPE), as well as stretching exercises. Quality of life (QoL) was assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30), fatigue using the Functional Assessment of Chronic Illness Therapy-Fatigue scale (FACIT-F), functional capacity using the Six Minute Walk Test (6MWT), and muscle strength using the 30 Second Sit to Stand Test (30s-STST) and handgrip dynamometry (HGT). Analyses of covariance (ANCOVA), responder analyses based on the Minimal Clinically Important Difference (MCID), and effect sizes (ηp2) were performed. Results: The intervention group showed significant and clinically meaningful improvements in fatigue (FACIT-F: +4.53; p < 0.001; ηp2 = 0.135), global QoL (+9.22; p = 0.006), physical function, functional capacity (+24.16 m in the 6MWT; p = 0.006), and muscle strength (30s-STST: +2.71 repetitions; handgrip: +3.32 kg; p < 0.001). A total of 63.3% of participants were responders for fatigue compared with 13.3% in the control group (NNT = 2.00). Functional improvements showed moderate correlations with fatigue and global health status. Among symptoms, only insomnia demonstrated a significant reduction. Conclusions: A brief, supervised, multimodal TEP of moderate to vigorous intensity appears to be an effective, safe, and clinically relevant intervention to improve fatigue, QoL, and functional capacity in patients with cancer, with potential applicability in multidisciplinary oncologic care.
Open AccessEffects of a 6-Week Supervised Multimodal Exercise Program on Cancer-Related Fatigue, Quality of Life and Physical Function During Active Treatment: A Randomized Controlled Trial
Background: Reduced quality of life, cancer-related fatigue, and functional impairment are common during and after oncologic treatment. Although therapeutic exercise is effective, evidence on brief, supervised programs of moderate to vigorous intensity remains limited, despite their greater clinical feasibility. This study evaluated the effectiveness of a six-week multimodal Therapeutic Exercise Program (TEP) in patients with cancer. Methods: A randomized controlled clinical trial (NCT05816187) was conducted with 110 patients with cancer (stages I–III), assigned to either an intervention group (supervised TEP, three sessions per week for six weeks) or a control group (usual care). The program included cardiorespiratory and strength training with intensity monitored using the Rating of Perceived Exertion (RPE), as well as stretching exercises. Quality of life (QoL) was assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30), fatigue using the Functional Assessment of Chronic Illness Therapy-Fatigue scale (FACIT-F), functional capacity using the Six Minute Walk Test (6MWT), and muscle strength using the 30 Second Sit to Stand Test (30s-STST) and handgrip dynamometry (HGT). Analyses of covariance (ANCOVA), responder analyses based on the Minimal Clinically Important Difference (MCID), and effect sizes (ηp2) were performed. Results: The intervention group showed significant and clinically meaningful improvements in fatigue (FACIT-F: +4.53; p < 0.001; ηp2 = 0.135), global QoL (+9.22; p = 0.006), physical function, functional capacity (+24.16 m in the 6MWT; p = 0.006), and muscle strength (30s-STST: +2.71 repetitions; handgrip: +3.32 kg; p < 0.001). A total of 63.3% of participants were responders for fatigue compared with 13.3% in the control group (NNT = 2.00). Functional improvements showed moderate correlations with fatigue and global health status. Among symptoms, only insomnia demonstrated a significant reduction. Conclusions: A brief, supervised, multimodal TEP of moderate to vigorous intensity appears to be an effective, safe, and clinically relevant intervention to improve fatigue, QoL, and functional capacity in patients with cancer, with potential applicability in multidisciplinary oncologic care.
- Open Access
- 6 March 2026
- Published by Springer Nature in European Journal of Applied Physiology
- Vol. 126 (4) , 2361-2362
Correction: Adaptation of mtDNA content to endurance training, a cross-sectional study and an endurance training intervention
- 6 March 2026
- Published by Springer Nature in European Journal of Applied Physiology
- Vol. 126 (4) , 2361-2362
Open AccessCorrection: Adaptation of mtDNA content to endurance training, a cross-sectional study and an endurance training intervention
- Open Access
- 5 December 2025
- Published by Springer Nature in European Journal of Applied Physiology
- Vol. 126 (4) , 2349-2359
Adaptation of mtDNA content to endurance training, a cross-sectional study and an endurance training intervention
Background: Maximal oxygen uptake (VO 2max ) is the gold standard for assessing cardiopulmonary fitness. However, the link between VO 2max and mitochondrial function is complex, with no direct causality proven. Analysing mtDNA copy number offers an innovative way to understand aerobic performance by measuring mitochondrial biogenesis, although its relation to physical performance and fitness is not well studied, especially in trained individuals. Objective: This study aimed to compare VO 2max and mtDNA copy number in blood leukocytes between highly trained runners and nontrained men. It also examined how leukocyte mtDNA content adapts to a 6-week HIIT aerobic training programme in nontrained individuals. Methods: We conducted a cross-sectional study with 20 highly trained runners and 20 nontrained healthy subjects. Then, we implemented a 6-week HIIT training programme for the nontrained group, comparing their VO 2max and mtDNA copy number to a control group. Participants trained 4 min/4 min HIIT treadmill running, three times a week. Results: The cross-sectional part showed that highly trained runners had significantly higher mtDNA copy numbers than nontrained subjects ( p = 0.046; d = 0.652; 95% CI: [0.01, 1.28]; [medium–large effect]); further, we observed a significant positive correlation between mtDNA copy number and VO 2max combining both groups ( p = 0.013; R 2 = 0.153 [small–moderate effect]). After the 6-week HIIT programme, the intervention group showed significant increases in both VO 2max ( p < 0.001) and mtDNA copy number ( p = 0.015), with large and medium effect sizes, respectively. The intervention group’s mtDNA copy number increased by 321.6 ± 391.6%; 95% CI: [120.2, 522.9], compared to 12.8 ± 32.8%; 95% CI: [− 5.4, 30.9] in controls, indicating substantial interindividual variability, which could be attributed to a combination of biological factors, but we also observed indications of a potential responder versus non-responder pattern. Conclusion: These findings align with previous research, indicating that mtDNA copy number correlates with VO 2max , being higher in highly trained runners than in nontrained subjects, and increasing with training after a 6-week HIIT intervention. This study is novel in showing that a 6-week HIIT programme significantly boosts leukocyte mtDNA content, enhancing our understanding of individual adaptations to endurance training.
- 5 December 2025
- Published by Springer Nature in European Journal of Applied Physiology
- Vol. 126 (4) , 2349-2359
Open AccessAdaptation of mtDNA content to endurance training, a cross-sectional study and an endurance training intervention
Background: Maximal oxygen uptake (VO 2max ) is the gold standard for assessing cardiopulmonary fitness. However, the link between VO 2max and mitochondrial function is complex, with no direct causality proven. Analysing mtDNA copy number offers an innovative way to understand aerobic performance by measuring mitochondrial biogenesis, although its relation to physical performance and fitness is not well studied, especially in trained individuals. Objective: This study aimed to compare VO 2max and mtDNA copy number in blood leukocytes between highly trained runners and nontrained men. It also examined how leukocyte mtDNA content adapts to a 6-week HIIT aerobic training programme in nontrained individuals. Methods: We conducted a cross-sectional study with 20 highly trained runners and 20 nontrained healthy subjects. Then, we implemented a 6-week HIIT training programme for the nontrained group, comparing their VO 2max and mtDNA copy number to a control group. Participants trained 4 min/4 min HIIT treadmill running, three times a week. Results: The cross-sectional part showed that highly trained runners had significantly higher mtDNA copy numbers than nontrained subjects ( p = 0.046; d = 0.652; 95% CI: [0.01, 1.28]; [medium–large effect]); further, we observed a significant positive correlation between mtDNA copy number and VO 2max combining both groups ( p = 0.013; R 2 = 0.153 [small–moderate effect]). After the 6-week HIIT programme, the intervention group showed significant increases in both VO 2max ( p < 0.001) and mtDNA copy number ( p = 0.015), with large and medium effect sizes, respectively. The intervention group’s mtDNA copy number increased by 321.6 ± 391.6%; 95% CI: [120.2, 522.9], compared to 12.8 ± 32.8%; 95% CI: [− 5.4, 30.9] in controls, indicating substantial interindividual variability, which could be attributed to a combination of biological factors, but we also observed indications of a potential responder versus non-responder pattern. Conclusion: These findings align with previous research, indicating that mtDNA copy number correlates with VO 2max , being higher in highly trained runners than in nontrained subjects, and increasing with training after a 6-week HIIT intervention. This study is novel in showing that a 6-week HIIT programme significantly boosts leukocyte mtDNA content, enhancing our understanding of individual adaptations to endurance training.
- Open Access
- 20 November 2025
- Published by MDPI AG in Journal of Functional Morphology and Kinesiology
- Vol. 10 (4) , 453
Improving Quality of Life Through Supervised Exercise in Oncology: A Systematic Review and Meta-Analysis of Randomized Trials in Breast and Prostate Cancer
Background: Cancer treatments often reduce quality of life (QoL), and non-pharmacological options are limited. Supervised exercise shows promise, but its effectiveness across exercise types and patient subgroups is unclear. Objective: This study aimed to assess the impact of supervised exercise on QoL in breast and prostate cancer patients, considering exercise type, duration, and patient characteristics. Methods: A systematic review and meta-analysis including 26 randomized controlled trials (RCTs) and approximately 3500 participants was conducted according to PRISMA guidelines. PubMed, Web of Science, PEDro, SciELO, Cochrane, and Scopus were searched for randomized controlled trials (RCTs) published between 2014 and 2024. Eligible studies involved adults with breast or prostate cancer undergoing supervised exercise versus usual care or unsupervised activity. Risk of bias was assessed with the Cochrane RoB 2.0 tool, methodological quality with the PEDro scale, and certainty of evidence using the GRADE approach. Results: Supervised exercise was associated with significant improvements in QoL (SMD = 0.46; 95% CI: 0.22–0.70; p < 0.001), with considerable heterogeneity (I2 = 91.5%). Combined programs had the greatest effect (SMD = 0.77), followed by high-intensity interval training (HIIT) (SMD = 0.30). Shorter interventions (≤12 weeks) yielded larger improvements. Effects were more consistent in women with breast cancer. Overall, the certainty of the evidence was low. Conclusions: Supervised therapeutic exercise is associated with significant improvements in QoL in breast and prostate cancer patients. Combined and well-structured programs, particularly of short duration, appear especially beneficial. These findings support the integration of supervised exercise into standard oncological care. Further research should explore long-term sustainability and optimize interventions for specific patient profiles.
- 20 November 2025
- Published by MDPI AG in Journal of Functional Morphology and Kinesiology
- Vol. 10 (4) , 453
Open AccessImproving Quality of Life Through Supervised Exercise in Oncology: A Systematic Review and Meta-Analysis of Randomized Trials in Breast and Prostate Cancer
Background: Cancer treatments often reduce quality of life (QoL), and non-pharmacological options are limited. Supervised exercise shows promise, but its effectiveness across exercise types and patient subgroups is unclear. Objective: This study aimed to assess the impact of supervised exercise on QoL in breast and prostate cancer patients, considering exercise type, duration, and patient characteristics. Methods: A systematic review and meta-analysis including 26 randomized controlled trials (RCTs) and approximately 3500 participants was conducted according to PRISMA guidelines. PubMed, Web of Science, PEDro, SciELO, Cochrane, and Scopus were searched for randomized controlled trials (RCTs) published between 2014 and 2024. Eligible studies involved adults with breast or prostate cancer undergoing supervised exercise versus usual care or unsupervised activity. Risk of bias was assessed with the Cochrane RoB 2.0 tool, methodological quality with the PEDro scale, and certainty of evidence using the GRADE approach. Results: Supervised exercise was associated with significant improvements in QoL (SMD = 0.46; 95% CI: 0.22–0.70; p < 0.001), with considerable heterogeneity (I2 = 91.5%). Combined programs had the greatest effect (SMD = 0.77), followed by high-intensity interval training (HIIT) (SMD = 0.30). Shorter interventions (≤12 weeks) yielded larger improvements. Effects were more consistent in women with breast cancer. Overall, the certainty of the evidence was low. Conclusions: Supervised therapeutic exercise is associated with significant improvements in QoL in breast and prostate cancer patients. Combined and well-structured programs, particularly of short duration, appear especially beneficial. These findings support the integration of supervised exercise into standard oncological care. Further research should explore long-term sustainability and optimize interventions for specific patient profiles.